Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Multicenter Real-World Registry Assessing the Impact of the Use of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer

NCT05712473 is registered in ClinicalTrials.gov with Lantheus Medical Imaging as lead sponsor.

NCT NCT05712473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05712473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Multicenter Real-World Registry Assessing the Impact of the Use of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer
Lead sponsor
Lantheus Medical Imaging
Phase
Observational
Overall status
Active, not recruiting
Start date
May 22, 2023
Completion date
May 31, 2031
Enrollment
500 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer